4.3 Article

Pregnancies in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor

Journal

LEUKEMIA RESEARCH
Volume 37, Issue 10, Pages 1216-1221

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.leukres.2013.07.020

Keywords

Imatinib; Nilotinib; Chronic myeloid leukemia; Pregnancy

Funding

  1. Terry Fox Foundation
  2. Terry Fox Run for Cancer Research

Ask authors/readers for more resources

We presented our experience in chronic myeloid leukemia (CML) patients who conceived children and/or became pregnant while receiving tyrosine kinase inhibitor (TKI). Among 7 male patients, 7 pregnancies resulted in the birth of 7 healthy babies. Among 18 female patients, 8 ended in elective abortion; 3 had spontaneous abortion, and 7 carried to term, resulting in the birth of 8 healthy babies. All children have normal growth and development. All patients remain in TKI therapy and in good response. It is suggested that female patients are advised to practice adequate contraception. No special precautions apply for male patients receiving TKI. (C) 2013 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available